Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 246Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Striking balance between expedited review and expecting efficacious anticancer drug and biologics: An ongoing challenge

Chary Krishnan Vengadaragava, Ramesh Anita

Year : 2017| Volume: 8| Issue : 4 | Page no: 176-179

   This article has been cited by
1 The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine
Ariel Kantor,Susanne B. Haga
Journal of Personalized Medicine. 2021; 11(1): 45
[Pubmed]  [Google Scholar] [DOI]


Read this article